Genentech’s Faricimab Meets Primary Endpoint and Shows Strong Durability Across Two Global …,

8 Clinical Trials.gov. A study to evaluate the efficacy and safety of faricimab in participants with neovascular age-related macular degeneration (TENAYA) …, 8 Clinical Trials.gov. A study to evaluate the efficacy and safety of faricimab in participants with neovascular age-related macular degeneration (TENAYA) …, Read More

Scroll to Top